Plantar Fasciitis Shoes Women Market Report: Sales Volume, Market Share, Leading Brands & Market Trends

PAPLUS is the best-performing plantar fasciitis shoes women brand in July 2026, moving 12,000 units across 2 ASINs for 23.1% of Top 10 volume. BESKAR follows with 10,000 units (19.2%), ahead of Dr. Scholl's on 6,000 units (11.5%).

Volume is spread across 9 brands, with the top three holding 53.8% between them. No single label controls the shelf, which usually leaves room for a well-differentiated listing to take share without outspending an incumbent. Average selling prices among the leaders run from $8.49 to $10.99, which frames the price band a competing listing has to justify.

Based on July 2026 data, this shortlist surfaces the two kinds of ASIN worth keeping an eye on — the ones that just broke into the Top 10, and the ones growing fastest month over month. On the growth side, B0D5FQ33R3 leads positive momentum with ▲ 100.0% MoM growth on 200 units, with B0DPLQBRY3 close behind at ▲ 100.0% MoM on 200 units.

The two signals carry different weight. A fresh entrant means share has already changed hands — an incumbent gave up its place to make room, so any competitive set drawn up a month ago is now out of date. A steep growth rate works as the earlier warning: it marks demand that is still compounding, usually a month or two before the ranking catches up to it.